Immune Analysis Facility Data for Grants

The Immune Analysis Facility (IAF), part of the Center for Immunotherapy at Roswell Park Cancer Institute, is a shared resource responsible for serial monitoring of immunologic functions in patients with cancer, those who are treated with biologic therapies, and those who participate in clinical trials or research protocols. The IAF makes available to its users a broad range of state-of-the-art immunologic assays, performed under a rigorous quality control program. In addition, as advances in immunobiology occur and new assays are requested by the users, the IAF performs pre-clinical evaluations of the assays and, when they become reliable and standardized, adds them to the available assay list. The IAF offers consultation regarding optimal immunologic assessment and assay development for innovative approaches to evaluate immune responses. They provide expert advice regarding the types of assays for immune monitoring and data interpretation tailored to fit the endpoints of each specific clinical trial.

The IAF maintains extensive quality control (QC) and quality assurance (QA) programs to ensure the validity of test results.

Seahorse Extracellular Flux Analyzer

The Seahorse Extracellular Flux Analyzer is housed at the Roswell Park Center for Immunotherapy. This technology simultaneously measures oxygen consumption rate (OCR) and extra cellular acidification rate (ECAR), indicators of mitochondrial respiration and glycolysis respectively, in a microplate, in real-time. This instrument allows us to study substrate utilization, mitochondrial function, energy expenditure, bioenergetics health of cells, and the shift between the two pathways, oxidative phosphorylation (OXPHOS) and glycolysis. The OCR/ECAR ratio can determine dominance of glycolysis or OXPHOS as the cells differentiate. Real-time OCR is determined during sequential treatments with oligomycin, FCCP, and antimycin-A/rotenone supplied by Mito-Stress test kit, and (ECAR) is determined by glucose, oligomycin and 2-DG treatments which are the components of Glyco-Stress test kit. By using the Mito Stress test kit, we can determine maximal respiration and spare respiratory capacity, an indicator of mitochondrial function. By using Glyco Stress test kit, we can examine the ability of cells to undergo rapid glycolytic switch upon stimulation, a hallmark of functional T cell effectors. Investigators can use this technology to assess metabolic changes of cancer and immune cells to various clinically relevant conditions, including drug exposure and hypoxia.